1 |
Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of Moyamoya disease [J]. Exp Ther Med, 2019, 17(3): 1977-1984.
|
2 |
Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives [J]. Lancet Neurol, 2008, 7(11): 1056-1066.
|
3 |
Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome [J]. N Engl J Med, 2009, 360(12): 1226-1237.
|
4 |
Baba T, Houkin K, Kuroda S. Novel epidemiological features of Moyamoya disease [J]. J Neurol Neurosurg Psychiatry, 2008, 79(8): 900-904.
|
5 |
Wakai K, Tamakoshi A, Ikezaki K, et al. Epidemiological features of Moyamoya disease in Japan: findings from a nationwide survey [J]. Clin Neurol Neurosurg, 1997, 99 Suppl 2: S1-S5.
|
6 |
Kuriyama S, Kusaka Y, Fujimura M, et al. Prevalence and clinicoepidemiological features of Moyamoya disease in Japan: findings from a nationwide epidemiological survey [J]. Stroke, 2008, 39(1): 42-47.
|
7 |
Liu W, Morito D, Takashima S, et al. Identification of RNF213 as a susceptibility gene for Moyamoya disease and its possible role in vascular development [J]. PLoS One, 2011, 6(7): e22542.
|
8 |
Kamada F, Aoki Y, Fau-Narisawa A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene [J]. J Hum Genet, 2011, 56(1): 34-40.
|
9 |
Wu Z, Jiang H, Zhang L, et al. Molecular analysis of RNF213 gene for Moyamoya disease in the Chinese Han population [J]. PLoS One, 2012, 7(10): e48179.
|
10 |
Zhang Q, Liu Y, Zhang D, et al. RNF213 as the major susceptibility gene for Chinese patients with Moyamoya disease and its clinical relevance [J]. J Neurosurg, 2017, 126(4): 1106-1113.
|
11 |
Suzuki J, Takaku A. Cerebrovascular "Moyamoya" disease. Disease showing abnormal net-like vessels in base of brain [J]. Arch Neurol, 1969, 20(3): 288-299.
|
12 |
Mineharu Y, Takenaka K, Yamakawa H, et al. Inheritance pattern of familial Moyamoya disease: autosomal dominant mode and genomic imprinting [J]. J Neurol Neurosurg Psychiatry, 2006, 77(9): 1025-1029.
|
13 |
Mertens R, Graupera M, Gerhardt H, et al. The genetic basis of Moyamoya disease [J]. Transl Stroke Res, 2022, 13(1): 25-45.
|
14 |
Kamada F, Aoki Y, Narisawa A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene [J]. J Hum Genet, 2011, 56(1): 34-40.
|
15 |
Morito D, Nishikawa K, Hoseki J, et al. Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state [J]. Sci Rep, 2014, 4: 4442.
|